Theravance Biopharma
TBPH
#6854
Rank
A$0.75 B
Marketcap
Country
$15.32
Share price
-1.44%
Change (1 day)
-5.63%
Change (1 year)

Theravance Biopharma (TBPH) - Total debt

Total debt on the balance sheet as of September 2024 : A$71.85 Million

According to Theravance Biopharma 's latest financial reports the company's total debt is A$71.85 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Theravance Biopharma - Total debt on balance sheet (from 2016 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$72.15 M-5.86%
2022-12-31A$76.64 M-91.7%
2021-12-31A$0.92 B5.01%
2020-12-31A$0.87 B20.61%
2019-12-31A$0.72 B13.06%
2018-12-31A$0.64 B125.04%
2017-12-31A$0.28 B-7.23%
2016-12-31A$0.30 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$1.39 B 1,843.92%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.84 M-84.90%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.24 M-92.70%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.90 B 10,897.98%๐Ÿ‡บ๐Ÿ‡ธ USA